Cargando…
COVID-19 -Tuberculosis interactions: When dark forces collide
The SARS-2 pandemic which has moved with frightening speed over the last 5 months has several synergies with another older, and far more neglected airborne disease, tuberculosis. Patients with tuberculosis are not only more likely to be infected by SARS-CoV-2 but also likely to have adverse outcomes...
Autores principales: | Udwadia, Zarir F., Vora, Agam, Tripathi, Awatansh R., Malu, Ketan N., Lange, Christoph, Sara Raju, Reyma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tuberculosis Association of India. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362784/ https://www.ncbi.nlm.nih.gov/pubmed/33308662 http://dx.doi.org/10.1016/j.ijtb.2020.07.003 |
Ejemplares similares
-
The N-95 mask: Invaluable ally in the battle against the COVID-19 pandemic
por: Udwadia, Zarir F., et al.
Publicado: (2020) -
How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus
por: Udwadia, Zarir F., et al.
Publicado: (2020) -
Favipiravir: A new and emerging antiviral option in COVID-19
por: Agrawal, Umang, et al.
Publicado: (2020) -
Treating household contacts of MDR-TB patients: Are we being too hasty?
por: Udwadia, Zarir F., et al.
Publicado: (2023) -
Fibrotic interstitial lung disease occurring as sequelae of COVID-19 pneumonia despite concomitant steroids
por: Udwadia, Zarir Farokh, et al.
Publicado: (2021)